DOI: 10.1123/ijsnem.10.2.199 Pooyandjoo, M., Nouhi, M., Shab-Bidar, S., Djafaroan, K., & Olyaeemanesh, A
A triple receptor agonist peptide targeting GLP-1, GIP, and glucagon pathways, studied for multi-receptor signaling mechanisms and metabolic pathway interactions in controlled laboratory settings
They mimic slightly different chemicals in the body and bind to different receptors
Explore protein picks and fiber finds : The QR code within the GLP-1 brochure leads to a product page that highlights protein and fiber options
The submissions feature ASC36, a once-monthly to once-quarterly peptide amylin receptor agonist, and ASC36_35 FDC, a potentially first-in-class once-monthly single injection co-formulating ASC36 with GLP-1R/GIPR agonist ASC35
Rare but serious Pancreatitis Severe allergic reaction Worsening of diabetic retinopathy in some patients with type 2 diabetes (semaglutide specifically) Bowel obstruction in patients with prior gastrointestinal surgery We review your history for the conditions that raise these risks before prescribing, and we tell you which symptoms mean stop the medication and call us